Eyconis logo

Eyconis

Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.

eyconis.com

Company Details

Founded

2024

Employees

Between 10 - 50 employees

Raised

$60,251,248

Public

No

Acquired

No

CEO

Mark J. BachledaMark J. Bachleda

Founders

Emmett Cunningham
Emmett Cunningham

Company Collections

These are collections Eyconis is a part of. Click on the collection name to view similar companies.